Home › Entities › academia › Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials

Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials

Research article (Leukemia & lymphoma/Leukemia and lymphoma, 2017) · cited 45× · AI/ML
academia openalex:W2767924245
Press Enter · cited answer in seconds

Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials

Summary

Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials is a scholarly article[1].

Key Facts

  • Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials's instance of is recorded as scholarly article[2].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials. Retrieved May 24, 2026, from https://4ort.xyz/entity/severe-pegaspargase-hypersensitivity-reaction-rates-grade-3-with-intravenous-infusion-vs-intramuscular-injection-analysi
MLA “Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/severe-pegaspargase-hypersensitivity-reaction-rates-grade-3-with-intravenous-infusion-vs-intramuscular-injection-analysi.
BibTeX @misc{4ortxyz_severe-pegaspargase-hypersensitivity-reaction-rates-grade-3-with-intravenous-infusion-vs-intramuscular-injection-analysi_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials}}, year = {2026}, url = {https://4ort.xyz/entity/severe-pegaspargase-hypersensitivity-reaction-rates-grade-3-with-intravenous-infusion-vs-intramuscular-injection-analysi}, note = {Accessed: 2026-05-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials — https://4ort.xyz/entity/severe-pegaspargase-hypersensitivity-reaction-rates-grade-3-with-intravenous-infusion-vs-intramuscular-injection-analysi (retrieved 2026-05-24)

Canonical URL: https://4ort.xyz/entity/severe-pegaspargase-hypersensitivity-reaction-rates-grade-3-with-intravenous-infusion-vs-intramuscular-injection-analysi · Last refreshed: